Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Board/Management Information 2014

Aug 27, 2014

29871_rns_2014-08-27_5eef8e5e-0cdb-4813-8ae8-e973fdcd288b.zip

Board/Management Information

Open in viewer

Opens in your device viewer

Comment1

CoverPageHeader end CoverPageTitle START

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): August 25, 2014

CoverPageTitle END CoverPageRegistrant START

CME Group Inc. ______ (Exact name of registrant as specified in its charter)

Delaware 001-31553 36-4459170
___ (State or other jurisdiction _______ (Commission __ (I.R.S. Employer
of incorporation) File Number) Identification No.)
20 South Wacker Drive, Chicago, Illinois 60606
_________ (Address of principal executive offices) _____ (Zip Code)

Registrant’s telephone number, including area code: 312-930-1000

Not Applicable __________ Former name or former address, if changed since last report

CoverPageRegistrant END

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

PageBreak START

Top of the Form

PageBreak END Item START

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

As described in the attached press release, CME Group Inc. (the "Company") announced that James E. Parisi, its Senior Managing Director and Chief Financial Officer, informed the Company that he plans to retire from his position as Chief Financial Officer. Upon Mr. Parisi’s retirement, John W. Pietrowicz will assume the role of Chief Financial Officer. Mr. Pietrowicz, 50, has served as the Company’s Senior Managing Director, Business Development and Corporate Finance since 2010. He joined the organization in 2003 and since then has held various positions of increasing responsibility, including his most recent position of Managing Director and Deputy Chief Financial Officer from 2009 to 2010 and Managing Director, Corporate Finance and Treasury from 2006 to 2009. Upon his assumption of the role of Chief Financial Officer, we expect Mr. Pietrowicz will participate in the Company’s compensation program upon terms commensurate with other executive officers of the Company at the level of Senior Managing Director. There are no family relationships existing between Mr. Pietrowicz and any executive officer or director of the Company. There have been no transactions, and no transactions are currently proposed, in which the Company was or is to be a participant and in which Mr. Pietrowicz or any member of his immediate family had or will have an interest.

Item END Item START

Item 9.01 Financial Statements and Exhibits.

Press Release, dated August 27, 2014.

Item END

PageBreak START

Top of the Form

PageBreak END SignatureHeader START

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SignatureHeader END Signature START

Kathleen M. Cronin
Name: Kathleen M. Cronin
Title: Senior Managing Director, General Counsel & Corporate Secretary

Signature END PageBreak START

Top of the Form

PageBreak END

Exhibit Index

Exhibit No. Description
99.1 Press Release, dated August 27, 2014.

HTMLFooter START